It recommends healthcare practitioners should offer a low-dose combination of inhaled corticosteroids (ICS) and formoterol to be taken as needed for everyone aged 12 and over with newly diagnosed ...
When a person’s asthma is severe or isn’t managed well by typical protocols, they may be a good candidate for pulmonary ...
Biologic therapies are revolutionising severe asthma management, showcasing potential for remission, but cost and equitable ...
Long-awaited joint UK guidelines for asthma have today been finalised, overhauling recommendations to GPs for diagnostics and ...
Scientists at deCODE genetics, a subsidiary of Amgen, and collaborators have published a study in Journal of Allergy and ...
Singulair, a popular asthma medication, could be linked to severe side effects, including suicide, a study from the FDA found ...
Jasper Therapeutics faces financial challenges but strong buy ratings. Read why JSPR stock is poised for growth amid risks ...
Irish Independent on MSN1d
Patients with severe asthma suffer ‘delayed diagnosis and restricted access to drugs’, report saysA young teacher who suffers from severe asthma has spoken of how patients with the high-risk condition can be left on ...
USA: Recent findings published in The Journal of Allergy and Clinical Immunology highlight the potential for long-term ...
Scientists at deCODE genetics and collaborators have published a study in the Journal of Allergy and Clinical Immunology ...
The following is a summary of “Effect of Mepolizumab in airway’s remodelling in patients with late-onset severe asthma with ...
Researchers at National Jewish Health and colleagues have identified a mechanism involved in the formation of mucus plugs in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback